Kyowa Hakko Starts Marketing Cholesterol-Lowering Super Soy in the U.S., Europe

Apr 23, 2001, 01:00 ET from Kyowa Hakko Kogyo Co., Ltd.

    TOKYO, April 23 /PRNewswire/ -- Kyowa Hakko, a leading Japanese
 pharmaceutical and biotechnology company, announced it will start marketing in
 the U.S. and Europe CSPHP super soy, a food ingredient that has been made to
 enhance the natural, cholesterol-lowering properties of soy.
     To create CSPHP, Kyowa Hakko has for the first time combined soy protein
 hydrolyzate with phospholipids, creating an ingredient that can be added to a
 wide variety of food products, which in turn will inhibit the body's
 absorption of cholesterol.
     CSPHP is acknowledged by Japan's Ministry of Health, Labor and Welfare to
 be a Food for Specified Health Use and provides consumers around the world
 with a natural, cost-effective way to lower cholesterol.
     According to the U.S. Food and Drug Administration, excess cholesterol is
 one of the main causes of heart disease, a condition that costs the U.S.
 economy roughly $60 billion in lost productivity and medical expenses a year,
 and is the main cause of death in the U.S.
     A 3-gram dose of CSPHP taken daily for one month reduced the
 LDL-cholesterol level of volunteers by 17 percent, whereas the 25-gram daily
 dose of regular soy the FDA recommends reduces cholesterol by only 10 percent.
 Furthermore, the same dosage of CSPHP increased HDL-cholesterol by 14 percent.
     "This health food ingredient dramatically lowers a body's
 serum-cholesterol levels," said Tadayasu Furukawa, executive officer from
 Kyowa Hakko's Food Company.  "Of course soy is a natural product, which means
 it's safe to include in your everyday diet."
     Since CSPHP is heat-resistant, pH-neutral and stable when mixed with other
 food ingredients, it provides food producers with a safe, cost-effective
 ingredient they can add to a wide range of products and manufacturing
 processes.  Alternatively, CSPHP can be taken in powder or tablet form as a
 dietary supplement.
 
     About Kyowa Hakko -- World leaders in fermentation, biotechnology, and
 chemical synthesis, Kyowa Hakko develops, manufactures and markets
 pharmaceuticals, amino acids, nucleic acids, fine chemicals, and food
 ingredients.  Backed by more than half a century of manufacturing innovation,
 advanced technology, and a commitment to research, Kyowa Hakko's products are
 known for high quality, reliability and cost-effectiveness.
 
     For more information, please contact Ichiro Matsuura Manager, Corporate
 Communications Department KYOWA HAKKO KOGYO CO., LTD. 1-6-1 Ohtemachi,
 Chiyoda-ku Tokyo 100-8185 JAPAN TEL +81-3-3282-1903 FAX +81-3-3282-0990
 E-mail pr@kyowa.co.jp URL http://www.kyowa.co.jp .
 
     Alternatively, please contact Kyowa Hakko U.S.A., Inc.
 Marketing Department, 599 Lexington Avenue, Suite 4103, New York, NY 10022,
 TEL -- 212-319-5353 FAX -- 212-421-1283  Or Kyowa Hakko's West Coast office,
 85 Enterprise, Suite 430, Aliso Viejo, California 92656, TEL -- 949-425-0707
 FAX -- 949-425-0708.
 
 

SOURCE Kyowa Hakko Kogyo Co., Ltd.
    TOKYO, April 23 /PRNewswire/ -- Kyowa Hakko, a leading Japanese
 pharmaceutical and biotechnology company, announced it will start marketing in
 the U.S. and Europe CSPHP super soy, a food ingredient that has been made to
 enhance the natural, cholesterol-lowering properties of soy.
     To create CSPHP, Kyowa Hakko has for the first time combined soy protein
 hydrolyzate with phospholipids, creating an ingredient that can be added to a
 wide variety of food products, which in turn will inhibit the body's
 absorption of cholesterol.
     CSPHP is acknowledged by Japan's Ministry of Health, Labor and Welfare to
 be a Food for Specified Health Use and provides consumers around the world
 with a natural, cost-effective way to lower cholesterol.
     According to the U.S. Food and Drug Administration, excess cholesterol is
 one of the main causes of heart disease, a condition that costs the U.S.
 economy roughly $60 billion in lost productivity and medical expenses a year,
 and is the main cause of death in the U.S.
     A 3-gram dose of CSPHP taken daily for one month reduced the
 LDL-cholesterol level of volunteers by 17 percent, whereas the 25-gram daily
 dose of regular soy the FDA recommends reduces cholesterol by only 10 percent.
 Furthermore, the same dosage of CSPHP increased HDL-cholesterol by 14 percent.
     "This health food ingredient dramatically lowers a body's
 serum-cholesterol levels," said Tadayasu Furukawa, executive officer from
 Kyowa Hakko's Food Company.  "Of course soy is a natural product, which means
 it's safe to include in your everyday diet."
     Since CSPHP is heat-resistant, pH-neutral and stable when mixed with other
 food ingredients, it provides food producers with a safe, cost-effective
 ingredient they can add to a wide range of products and manufacturing
 processes.  Alternatively, CSPHP can be taken in powder or tablet form as a
 dietary supplement.
 
     About Kyowa Hakko -- World leaders in fermentation, biotechnology, and
 chemical synthesis, Kyowa Hakko develops, manufactures and markets
 pharmaceuticals, amino acids, nucleic acids, fine chemicals, and food
 ingredients.  Backed by more than half a century of manufacturing innovation,
 advanced technology, and a commitment to research, Kyowa Hakko's products are
 known for high quality, reliability and cost-effectiveness.
 
     For more information, please contact Ichiro Matsuura Manager, Corporate
 Communications Department KYOWA HAKKO KOGYO CO., LTD. 1-6-1 Ohtemachi,
 Chiyoda-ku Tokyo 100-8185 JAPAN TEL +81-3-3282-1903 FAX +81-3-3282-0990
 E-mail pr@kyowa.co.jp URL http://www.kyowa.co.jp .
 
     Alternatively, please contact Kyowa Hakko U.S.A., Inc.
 Marketing Department, 599 Lexington Avenue, Suite 4103, New York, NY 10022,
 TEL -- 212-319-5353 FAX -- 212-421-1283  Or Kyowa Hakko's West Coast office,
 85 Enterprise, Suite 430, Aliso Viejo, California 92656, TEL -- 949-425-0707
 FAX -- 949-425-0708.
 
 SOURCE  Kyowa Hakko Kogyo Co., Ltd.